Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Filing Type:

Year:

Date	Form	Description	Pages
04/15/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	3
04/09/24	EFFECT	Notice of Effectiveness	1
04/05/24	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents expand_more EX-5.1 EX-23.1 EX-FILING FEES	9
04/05/24	POS AM	Post-effective amendment to a registration statement that is not immediately effective upon filing Documents expand_more EX-23.1	34
04/03/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	3
03/28/24	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-2.1 EX-4.9 EX-12.1 EX-13.1 EX-15.1 EX-97.1	135
03/28/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	4
03/11/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	2
02/28/24	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	3
02/14/24	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	7